Coronavirus: Pfiz vaccine authorized in the United Kingdom …

The Health and Medical Products Regulatory Agency (MHRA) UK authorized on coronavirus vaccine who manufacture the American pharmaceutical product Pfizer with BioNTech and announced that a mass vaccination will begin next week. The first to receive it will be the groups at risk.

“Help is on the way. The MHRA has officially authorized the Pfizer / BioNTech vaccine for Covid-19. The NHS (National Health Service) is ready to start vaccination at the beginning of next week ”, announced Matt Hancock, British Minister for Health, on his social networks..

In this way, UK first country in the world to have a clinically approved vaccine for its supply.

The Ministry of Health reported in a statement that government accepted MHRA authorization for use of vaccine from Pfizer and BioNTech. “The government today accepted the recommendation of the Medicines and Health Products Regulatory Agency (MHRA) to approve the use of the Pfizer / BioNTech COVID-19 vaccine,” the text begins.

The statement states that The MHRA conducted “rigorous clinical trials and extensive data analysis” which concluded that the vaccine met “its strict standards for safety, quality and efficacy.”

“The Joint Committee on Vaccines and Immunizations (JCVI) will soon publish its final opinion for the priority groups that will receive the vaccine, including residents of nursing homes, health and care personnel, the elderly and the clinically extremely vulnerable, ”the text continues.

Hancock’s advance was also confirmed: “The vaccine will be available across the UK from next week. The NHS has decades of experience in implementing large-scale vaccination programs and will begin to implement its extensive immunization programs. preparations to provide care and support to all those eligible for immunization. “

The UK government has warned that, although mass vaccination will start shortly, it is necessary to maintain all sanitary measures to avoid new cases of coronavirus. “To help the vaccination program succeed, it is essential that everyone continue to play their part and adhere to the necessary restrictions in their region so that we can further suppress the virus. and allow the NHS to do its job without feeling overwhelmed“they ask.

Pfizer and BioNTech announced a few days ago that ongoing Phase 3 studies of their covid-19 vaccine have shown 95% efficacy. in a group of 44,000 volunteers. In adults over 65, in particular, the efficacy was 94%.

With this report, Pfizer and BioNTech have already requested, in addition, United States Food and Drug Administration authorization for use (FDA) “for Emergency Use Authorization (United States)”.

For its part, the European Medicines Agency (EMA) has announced its intention to approve Pfizer’s vaccine by December 29 and that of the pharmaceutical company Moderna by mid-January.

As, Pfizer and BioNTech have pointed out that they plan to manufacture around 50 million doses of their covid-19 vaccine in the remainder of 2020. and about $ 1.3 billion next year.

“We have increased our manufacturing capacities around the world in order to meet the strong demand due to the Covid-19 pandemic,” noted the American laboratory and the German biotechnology company.

“Based on current projections, we plan to produce up to 50 million doses of vaccine globally in 2020 and up to 1.3 billion doses in 2021“They officially added.